EAM Investors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-235,813
| Closed | -$4.04M | – | 250 |
|
|
2024
Q4 | $4.04M | Sell |
235,813
-36,821
| -14% | -$631K | 0.57% | 82 |
|
|
2024
Q3 | $5.45M | Sell |
272,634
-102,343
| -27% | -$2.05M | 0.81% | 19 |
|
|
2024
Q2 | $4.19M | Sell |
374,977
-247,109
| -40% | -$2.76M | 0.68% | 44 |
|
|
2024
Q1 | $4.11M | Buy |
+622,086
| New | +$4.11M | 0.64% | 56 |
|
|
2023
Q4 | – | Sell |
-967,146
| Closed | -$3.46M | – | 237 |
|
|
2023
Q3 | $3.46M | Buy |
967,146
+83,304
| +9% | +$298K | 0.67% | 21 |
|
|
2023
Q2 | $3.26M | Sell |
883,842
-151,910
| -15% | -$561K | 0.6% | 35 |
|
|
2023
Q1 | $3.43M | Sell |
1,035,752
-713,846
| -41% | -$2.36M | 0.67% | 21 |
|
|
2022
Q4 | $6.79M | Buy |
1,749,598
+322,438
| +23% | +$1.25M | 1.41% | 1 |
|
|
2022
Q3 | $3.47M | Buy |
1,427,160
+179,024
| +14% | +$435K | 0.75% | 16 |
|
|
2022
Q2 | $2.47M | Buy |
+1,248,136
| New | +$2.47M | 0.6% | 41 |
|